|
Volumn 8, Issue 8, 2002, Pages 2519-2523
|
Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
6 O ALKYLGUANINE DNA ALKYLTRANSFERASE;
6 O BENZYLGUANINE;
DEOXYRIBONUCLEOPROTEIN;
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
GUANINE;
METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;
O(6) BENZYLGUANINE;
O(6)-BENZYLGUANINE;
ADULT;
AGED;
ARTICLE;
BLADDER CANCER;
CANCER LOCALIZATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLON CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
ENZYME ACTIVITY;
FEMALE;
HUMAN;
HUMAN TISSUE;
MALE;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
RECTUM CANCER;
STOMACH CANCER;
ANIMAL;
CELL CULTURE;
CHO CELL;
DNA METHYLATION;
DNA REPAIR;
DRUG ANTAGONISM;
HAMSTER;
METABOLISM;
MIDDLE AGED;
NEOPLASM;
AGED;
AGED, 80 AND OVER;
ANIMAL;
ANTINEOPLASTIC AGENTS;
CHO CELLS;
DNA METHYLATION;
DNA REPAIR;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
GUANINE;
HAMSTERS;
HUMAN;
MALE;
MIDDLE AGE;
NEOPLASMS;
O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;
SUPPORT, U.S. GOV'T, P.H.S.;
TUMOR CELLS, CULTURED;
ANIMALS;
CRICETINAE;
HUMANS;
MIDDLE AGED;
|
EID: 0036023409
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (28)
|
References (29)
|